Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Comera Life Sciences logo — Comera Life Sciences transforms the formulation of biotherap...

Comera Life Sciences

Comera Life Sciences transforms the formulation of biotherapeutics for the ultimate benefit of patients

Founded 2014 United States Woburn, United States 2 employees Post Ipo Equity Total: $4.10M Biotechnology, Health Care +1

General Information

Company Name Comera Life Sciences
Founded Year 2014
Location United States Woburn, United States +1
Employees 2
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post Ipo Equity
Social

Get notified when Comera Life Sciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Comera Life Sciences

Comera Life Sciences is a formulation innovator in the field of protein therapeutics, striving to transform the formulation of biotherapeutics for the ultimate benefit of patients. The company's proprietary technology offers patented, FDA-friendly excipients catering to a wide range of therapeutic biologics, making life-saving medicines easier to administer, less immunogenic, more stable, and efficient to produce. Through their efforts to enhance therapeutic protein formulations, Comera aims to turn biologic molecules into biobetters, thereby improving the overall patient experience and potentially extending a product’s lifecycle. Founded in 2014 by prolific entrepreneur David Soane, the company is driven by a team of experienced scientists who are committed to advancing their technology. Recent investment of $4.10M in Post-IPO Equity was made on 01 August 2023. Comera Life Sciences operates at the intersection of Biotechnology, Health Care, and Health and Wellness.

Taxonomy: Biotherapeutics, Biopharmaceuticals, Formulation Technology, Excipient Development, Drug Delivery Systems, Therapeutic Biologics, Protein Stabilization, Biobetters, Antibody Formulations, Subcutaneous Administration, High Concentration Formulations, Parenteral Biologics, Excipient Technology, Biophysical Characterization, Surfactant Replacements

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 01 Aug 2023
Series A •••••• 2
Investor Investor
04 Apr 2018

Comera Life Sciences Alternatives & Competitors

Comera Life Sciences vs
GlycoEra AG
GlycoEra AG Switzerland

Advancing Glycan Mediated Therapy

Series B
30 employees
Biotechnology, Health Care
Comera Life Sciences vs
Arsia Therapeutics
Arsia Therapeutics

Enhancing accessibility and patient comfort while lowering healthcare costs through advanced subcuta...

Seed
Biotechnology, Health and Wellness
Comera Life Sciences vs
BioAtla, Inc.
BioAtla, Inc. United States

Safer, more effective drugs for cancer using a proprietary next generation antibody discovery and ev...

IPO
35 employees
Biotechnology, Health Care

FAQ About Comera Life Sciences

Comera Life Sciences transforms the formulation of biotherapeutics for the ultimate benefit of patients
Comera Life Sciences was founded in 2014.
Comera Life Sciences is headquartered in Woburn, United States.
Comera Life Sciences operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Comera Life Sciences has approximately 2 employees.
Comera Life Sciences has completed 2 funding rounds, raising a total of $4.10M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Comera Life Sciences include GlycoEra AG, Arsia Therapeutics, BioAtla, Inc., ChitogenX, Biological Mimetics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Comera Life Sciences and GlycoEra AG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Comera Life Sciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy